Mungipa Pharmaceuticals Private Limited
About Mungipa Pharmaceuticals Private Limited
Data last updated:
Mungipa Pharmaceuticals Private Limited is a private limited company based in Siliguri, West Bengal, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 04 June 2013 and has been in existence for over 13 years.
The company is registered with the Registrar of Companies (ROC), Kolkata, under CIN U74900WB2013PTC194226.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It was formerly known as Mangaldham Marketing Private Limited. It is led by directors Pritam Agarwal and Kamlesh Kumar Agarwal.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Unity Building Shop No.20 Sevoke Road, Siliguri, West Bengal, India – 734001.
As per the financials filed for FY 2023, the company reported a revenue of ₹25,000. For the same year it recorded a net profit of ₹143 (net margin 0.6%) and EBITDA of -₹14,812 (EBITDA margin -59.2%).
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN history
Mungipa Pharmaceuticals has one previous CIN (Corporate Identification Number): U70102WB2013PTC194226. The current CIN is U74900WB2013PTC194226, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U74900WB2013PTC194226 | Current |
| U70102WB2013PTC194226 | Previous |
Contact details
Mungipa Pharmaceuticals Private Limited's registered office is in Siliguri, West Bengal. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressUnity Building Shop No.20 Sevoke Road, Siliguri, West Bengal, India – 734001
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Mungipa Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Mungipa Pharmaceuticals Private Limited
FY 2025 filings availableMungipa Pharmaceuticals Private Limited reported revenue of ₹25,000 for FY 2023.
Financial Statement Summary
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | ₹25,000 | ||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹14,812 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹143 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -59.2% | ||||
| Net Profit Margin | 0.6% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Mungipa Pharmaceuticals Private Limited, buy the company report.
Board of directors of Mungipa Pharmaceuticals Private Limited
Mungipa Pharmaceuticals has 2 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Pritam Agarwal | Director | 15 Oct 2014 | 12 Years 0 Months | Current |
| Kamlesh Kumar Agarwal Also directs: Allianza Enterprises LLP, Rasova Resorts LLP, Maa Sati Bhumi Infra Developers LLP and 5 more | Director | 03 Apr 2019 | 7 Years 7 Months | Current |
Auditor
Mungipa Pharmaceuticals Private Limited is audited by ARYA AGARWAL & ASSOCIATES for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| ARYA AGARWAL & ASSOCIATES | FY 2023 | 329343E |
Shareholding
The shareholding of Mungipa Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Mungipa Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Mungipa Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Mungipa Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Mungipa Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Mungipa Pharmaceuticals Private Limited has 5 board changes on record since 2014: 2 appointments and 3 cessations. The latest: Binod Kumar Agarwal ceased to be Director on 03 Apr 2019.
Frequently asked questions
Mungipa Pharmaceuticals is an active private limited company based in Siliguri, West Bengal, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 04 June 2013 (13+ years old) and is registered under CIN U74900WB2013PTC194226.
Mungipa Pharmaceuticals has 2 current directors:
- Pritam Agarwal - Director
- Kamlesh Kumar Agarwal - Director
The latest financial statements of Mungipa Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The CIN (Corporate Identification Number) of Mungipa Pharmaceuticals is U74900WB2013PTC194226. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Mungipa Pharmaceuticals was incorporated on 04 June 2013, making it 13+ years old. It is registered with the Registrar of Companies, Kolkata.
Binod Kumar Agarwal ceased to be Director on 03 Apr 2019. Kamlesh Kumar Agarwal was appointed as Director on 03 Apr 2019. Pravash Pani ceased to be Director on 08 Jan 2015. Mungipa Pharmaceuticals has 5 board changes on record in total.
The registered office of Mungipa Pharmaceuticals is at Unity Building Shop No.20 Sevoke Road, Siliguri, West Bengal, India – 734001.
Mungipa Pharmaceuticals operates in the pharma industry, in the drug formulation and development segment.
The compliance status of Mungipa Pharmaceuticals is compliant as of 08 September 2026. The company is actively filing with the Registrar of Companies.
Yes. Mungipa Pharmaceuticals was formerly known as Mangaldham Marketing Private Limited.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
